Estimated antiretroviral therapy coverage among people living with HIV in Senegal
Senegal: Estimated antiretroviral therapy coverage among people living with HIV was 77.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in Senegal, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Senegal recorded 77.0% for estimated antiretroviral therapy coverage among people living with hiv in 2025. That is the highest value across all 26 years on record.
That represents a change of up 1.3% on the previous year and up 75.0% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in Senegal peaked at 77.0% in 2025 and was at its lowest, 0.0%, in 2000.
Senegal ranks 64th of 143 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in Senegal, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 16.0% | — |
| 2008 | 19.0% | +18.8% |
| 2009 | 23.0% | +21.1% |
| 2010 | 26.0% | +13.0% |
| 2011 | 29.0% | +11.5% |
| 2012 | 27.0% | -6.9% |
| 2013 | 31.0% | +14.8% |
| 2014 | 38.0% | +22.6% |
| 2015 | 44.0% | +15.8% |
| 2016 | 51.0% | +15.9% |
| 2017 | 57.0% | +11.8% |
| 2018 | 65.0% | +14.0% |
| 2019 | 71.0% | +9.2% |
| 2020 | 73.0% | +2.8% |
| 2021 | 74.0% | +1.4% |
| 2022 | 74.0% | +0.0% |
| 2023 | 74.0% | +0.0% |
| 2024 | 76.0% | +2.7% |
| 2025 | 77.0% | +1.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 5.8% | 0.0% | 23.0% | 10 |
| 2010s | 43.9% | 26.0% | 71.0% | 10 |
| 2020s | 74.7% | 73.0% | 77.0% | 6 |
Countries ranked near Senegal
- 64 Antigua and Barbuda 77.0% compare
- 66 Tajikistan 76.0% compare
- 66 Morocco 76.0% compare
- 66 Central African Republic 76.0% compare
- 66 Canada 76.0% compare
More health data for Senegal
- Un projection of annual infant deaths, annual growth rate -1.58 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7598 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 835.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 2,496 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0592 units per person (2025)
- Population ages 05-09, male, annual growth rate 0.563 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0646 units per person (2025)
- Population ages 10-14, female, annual growth rate 0.6139 % change on previous year (2025)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in Senegal?
- Estimated antiretroviral therapy coverage among people living with hiv in Senegal was 77.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in Senegal?
- The highest recorded value was 77.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in Senegal?
- The lowest recorded value was 0.0% in 2000.
- How does Senegal rank for estimated antiretroviral therapy coverage among people living with hiv?
- Senegal ranks 64th out of 143 countries with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in Senegal?
- Over the last ten years it is up 75.0%. The long-run trend across the full record is volatile.
- Where does this Senegal data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).